Intervention Review

Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus

  1. Virginia Fernandes Moça Trevisani1,*,
  2. Aldemar A Castro2,
  3. João JFNN Ferreira Neves Neto3,
  4. Álvaro N Atallah4

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 20 FEB 2006

DOI: 10.1002/14651858.CD002265.pub2

How to Cite

Trevisani VFM, Castro AA, Ferreira Neves Neto JJFNN, Atallah ÁN. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD002265. DOI: 10.1002/14651858.CD002265.pub2.

Author Information

  1. 1

    UNISA (Santo Amaro University)/UNIFESP (Paulista Medicine School), Rheumatology/Internal Medicine and Therapeutics, Jardim Marajoara, Sao Paulo, Brazil

  2. 2

    State University of Heath Science, Department of Public Health, Maceió, Alagoas, Brazil

  3. 3

    Federal University of São Paulo, Surgery, São Paulo, Lapa, Brazil

  4. 4

    Universidade Federal de São Paulo / Escola Paulista de Medicina, Brazilian Cochrane Centre, São Paulo, SP, Brazil

*Virginia Fernandes Moça Trevisani, Rheumatology/Internal Medicine and Therapeutics, UNISA (Santo Amaro University)/UNIFESP (Paulista Medicine School), Rua Marie Satzke 119, Jardim Marajoara, Sao Paulo, 04664-150, Brazil. vmoca@uol.com.br. cochrane.dmed@epm.br.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

  1. Current Version

    Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus

    Virginia Fernandes Moça Trevisani, Aldemar A Castro, João JFNN Ferreira Neves Neto and Álvaro N Atallah

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD002265.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus

    VFM Trevisani, AA Castro, JF Neves Neto and AN Atallah

    Article first published online: 25 JAN 2006 | DOI: 10.1002/14651858.CD002265